FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

77365006: Dihydropyrimidine dehydrogenase deficiency (disorder)


Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
128409017 Dihydrouracil dehydrogenase (NADP^+^) deficiency en Synonym Active Initial character case insensitive SNOMED CT core
128410010 Dihydropyrimidine dehydrogenase deficiency en Synonym Active Case insensitive SNOMED CT core
128411014 Dihydrothymine dehydrogenase deficiency en Synonym Active Case insensitive SNOMED CT core
128412019 Sensitivity to fluorouracil toxicity en Synonym Active Case insensitive SNOMED CT core
128413012 Hereditary thymine-uraciluria en Synonym Active Case insensitive SNOMED CT core
128414018 Familial pyrimidinemia en Synonym Active Case insensitive SNOMED CT core
2974381011 Dihydrouracil dehydrogenase (nicotinamide adenine dinucleotide phosphate ^+^) deficiency en Synonym Active Case insensitive SNOMED CT core
4964974019 Dihydropyrimidine dehydrogenase deficiency (disorder) en Fully specified name Active Case insensitive SNOMED CT core
4964975018 DPD - dihydropyrimidine dehydrogenase deficiency en Synonym Active Case sensitive SNOMED CT core
503535019 Dihydrouracil dehydrogenase (NADP) deficiency en Synonym Active Initial character case insensitive SNOMED CT core
503536018 Familial pyrimidinaemia en Synonym Active Case insensitive SNOMED CT core
4964976017 A rare disorder of pyrimidine metabolism with characteristics of a variable phenotype ranging from absence of symptoms to severe neurological involvement with developmental delay, intellectual disability, and seizures. Additional signs and symptoms may include hypotonia, microcephaly, ocular abnormalities (such as microphthalmia, nystagmus, and strabismus), and autistic behavior, among others. Analysis of urine typically shows high levels of uracil and thymine. Patients are at risk of suffering from severe toxicity after the administration of the anti-neoplastic agent 5-fluorouracil. en Definition Active Case sensitive SNOMED CT core
4964977014 A rare disorder of pyrimidine metabolism with characteristics of a variable phenotype ranging from absence of symptoms to severe neurological involvement with developmental delay, intellectual disability, and seizures. Additional signs and symptoms may include hypotonia, microcephaly, ocular abnormalities (such as microphthalmia, nystagmus, and strabismus), and autistic behaviour, among others. Analysis of urine typically shows high levels of uracil and thymine. Patients are at risk of suffering from severe toxicity after the administration of the anti-neoplastic agent 5-fluorouracil. en Definition Active Case sensitive SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dihydrouracil dehydrogenase (NADP^+^) deficiency Is a Autosomal recessive hereditary disorder true Inferred relationship Some
Dihydrouracil dehydrogenase (NADP^+^) deficiency Is a Enzymopathy true Inferred relationship Some
Dihydrouracil dehydrogenase (NADP^+^) deficiency Is a Disorder of pyrimidine metabolism true Inferred relationship Some
Dihydrouracil dehydrogenase (NADP^+^) deficiency Occurrence Congenital false Inferred relationship Some
Dihydrouracil dehydrogenase (NADP^+^) deficiency Finding site Body system structure false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian emergency department reference set

Clinical finding foundation reference set

Problem/Diagnosis reference set

Back to Start